Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-01-10
1995-12-12
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514242, 514252, 514267, 514359, 514362, 514363, 514365, 514372, 514374, 514378, 514383, 514451, 514444, 514473, 514 99, 514461, 549 60, 549295, 549323, 549218, 549222, 544180, 544238, 544333, 544374, 548127, 548128, 548131, 548134, 548136, 548125, 548143, 548202, 548206, 548235, 548247, 5483657, 548255, 5482625, A61K 3153, C07D30702
Patent
active
054749956
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases, ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 3351468 (1967-11-01), Froehlich et al.
patent: 3743656 (1973-07-01), Brown et al.
patent: 4302461 (1981-11-01), Cherkofsky
patent: 4321118 (1982-03-01), Felder et al.
patent: 4427693 (1984-01-01), Haber
patent: 4432974 (1984-02-01), Haber
patent: 4539332 (1985-09-01), Biftu et al.
patent: 4585789 (1986-04-01), Okamoto et al.
patent: 4797417 (1989-01-01), Okamoto et al.
patent: 4820827 (1989-04-01), Haber
patent: 4853473 (1989-08-01), Fischer et al.
patent: 4855320 (1989-08-01), Chatterjee et al.
patent: 4929525 (1990-05-01), Kuroda et al.
patent: 4968817 (1990-11-01), Brima et al.
patent: 5094681 (1992-03-01), Kramer et al.
patent: 5145860 (1992-09-01), Takasugi et al.
patent: 5207817 (1993-05-01), Kramer et al.
patent: 5217971 (1993-06-01), Takasugi et al.
patent: 5229386 (1993-07-01), Takasugi et al.
patent: 5274072 (1993-12-01), Weaver et al.
Mona A. Ahmed, et al., Rev. Roum Chim., 38 (1), pp. 79-82 (1993).
M. A. Ahmed, et al., Egypt. J. Chem. 33 (3), pp. 291-295 (1990).
F. Toda, et al., J. Chem. Soc. Chem. Comm. (18), pp. 1234-1235 (1984).
V. K. Ahluwalia, et al., Synth. Commun., 19 (3-4), pp. 619-626 (1989).
Chem. Abstracts, vol. 86, No. 21, 155415p (May 23, 1977).
Chem. Abstracts, vol. 67, No. 17, 82088e (Oct. 23, 1967).
Chem. Abstracts, vol. 55, No. 4, 3553g (Feb. 20, 1961).
Dissertation K. J. Bamberg, Universitat Erlangen-Nurnberg 1961 11. Mitt.: Pharmazie 23, 69 (1968).
J. Indian Chem. Soc., vol. LIII, May 1976, pp. 490-495.
Tetrahedron Letters, vol. 30, No. 7, pp. 847-850, 1989.
Heterocycles, vol. 23, No. 8, 1985 pp. 1907-1910.
Chadwik, et al, Preparation of Thiophene Esters by the Nidsberg Reaction, (1972) pp. 2079-2081.
Preparation of 2(5H)-Furanones, pp. 173-177, Jan 1967.
Indian Journal of Chem. vol. 25B, Jul. 1986, pp. 760-761.
Indian Journal of Chem. vol. 29B, Oct. 1990, pp. 954-960.
J. Chem. Soc. Chem. Commun., 1987 pp. 649-650.
Joh, et al, Organometallics 1991, 10, 2493-2498.
Arzneim-Forsch. (Drus Res.) 25, Nr. 10 pp. 1629-1635 (1975) Lombardino, et al. Acidic Antiinflammatory Agents.
Nonsteroidal Antininflammatory Drugs, pp. 114-130, J. G. Lombardino (1985).
O'Banion, et al, Proc. Natl. Acad., Sci, USA, vol. 89, pp. 4888-4892 (1992).
K. Gans, et al., Journ. of Pharm. and Experimental Ther., vol. 254, (1), pp. 180-187 (1990), "Anti-Inflammatory and Safety Profile of DuP 697, a Novel Orally Effective Prostaglandin Synthesis Inhibitor".
Chem. Abstracts, vol. 55, No. 1, 502g (Jan. 9, 1961)-Farmaco Ed. Sci. vol. 15, 1960, Pavia It, pp. 442-450.
Chemische Berichet, vol. 116, pp. 3112-3124 (1983).
Journ of the Chem. Soc. Chem. Comm. No. 8, pp. 656-658 (1992).
Chem. and Pharm. Bull. vol. 29, No. 3, pp. 635-645 (1981).
Tetrahedron Letters, vol. 29, No. 28, pp. 3483-3486 (1988).
Ducharme Yves
Gauthier Jacques Y.
Leblanc Yves
Leger Serge
Prasit Petpiboon
Ivy C. Warren
Merck Frosst Canada Inc.
Owens Amelia
Panzer Curtis C.
Rose David L.
LandOfFree
Phenyl heterocycles as cox-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl heterocycles as cox-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl heterocycles as cox-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1359873